Recent Analyst Forecasts and Stock Ratings
Palvella Therapeutics, Inc. FAQ's
Palvella Therapeutics, Inc. has been rated by research analysts at Canaccord Genuity, Stifel Nicolaus, Cantor Fitzgerald in the past 90 days.
Palvella Therapeutics, Inc. has been rated by research analysts at Canaccord Genuity, Stifel Nicolaus, Cantor Fitzgerald in the past 90 days.